Form 4: Beam Therapeutics President Exercises Stock Options, Disposes of Shares
SEC Form 4 Filing
Giuseppe Ciaramella, President of Beam Therapeutics, exercised stock options and disposed of 53,500 shares of common stock on December 17, 2024.
Summary
- On December 17, 2024, Giuseppe Ciaramella, President of Beam Therapeutics, exercised stock options to acquire 53,500 shares of common stock at a price of $0.67 per share.
- Following the transaction, Ciaramella disposed of the 53,500 shares.
- After the reported transaction, Ciaramella directly owns 162,650 shares of Beam Therapeutics common stock.
- Ciaramella also directly owns 6,505 stock options.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock option exercises and share disposal. It doesn't inherently indicate positive or negative sentiment, but rather reflects standard executive compensation practices.
Industry Context
Form 4 filings are standard practice for corporate insiders to report transactions in their company's stock, providing transparency to investors.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in ownership by a company insider.
Key Dates
| Date | Description |
|---|---|
| February 26, 2018 | Vesting commencement date for the stock options. |
| May 08, 2028 | Expiration date of the stock options. |
| 12/17/2024 | Date of the transaction: exercising of stock options and disposal of shares. |
| 12/19/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.